RSS Feed

Portfolio News

July 27, 2012 - Dow Jones VentureWireHyperion Thera Goes Public as Investors Warm Up to Biotech
July 26, 2012 Amarin Announces FDA Approval of Vascepa(TM) (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia
July 26, 2012 - Dow Jones VentureWireHyperion Therapeutics Opens Up 5% Post-IPO
July 24, 2012 - Dow Jones VentureWireHistogenics Closes $49M Series A for Phase III Studies of Cartilage Implant
July 19, 2012 - Dow Jones VentureWirePharmaceutical Developer Durata Trades Up 8.1% Post-IPO
July 18, 2012 - Dow Jones VentureWireSofinnova Ventures, NEA Join $40M PIPE For Alimera Sciences
July 02, 2012 Amarin Announces Notice of Allowance for Additional U.S. Patent Covering AMR101
July 02, 2012 Tesaro’s 30% solution
June 28, 2012 Tesaro Completes $81M IPO; New Investor Sofinnova Joins Insiders in Offering
June 22, 2012 Volubill Named as a Leading Convergent Charging Software Provider by Infonetics Research
May 29, 2012 Amarin Announces U.S. Patent Issuance for AMR101
May 29, 2012 Cortina’s PON Innovation Accelerates Adoption in Fast Growing 10G EPON and EPON/GPON Markets
May 24, 2012 Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions
May 22, 2012 Sorbent Therapeutics’ CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
May 18, 2012 Ocera Therapeutics receives CE Mark for Zysa(TM) for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d)

< More recent articles | Past articles >

Sofinnova News

November 03, 2012 - Sun SentinelBiotech Industry Aims for Growth
October 22, 2012 - Xconomy Who Will Survive the Biotech VC Downturn? The Young and the Proven
October 15, 2012 - XconomyWhich VCs Are Poised to Cash In On the Biotech IPOs of 2012? – Sofinnova Ventures
August 06, 2012 Glint of IPO Optimism
January 30, 2012 VCs Eye Bargain IPOs as Option for New Investment

< More recent | Past articles >

Events

October 28, 2013Mike Powell, BioNetwork West 2013 - "The Outlook for Traditional Venture Capital Firms: Evolving Trends and Opportunities"
October 22, 2013Sofinnova Japan BioPharma Partnering Conference
July 31, 2013Jim Healy, 2013 BioUtah Masters Series Funding Panel in SLC
July 10, 2013Mike Powell - Life Science Innovation Northwest "Start Me Up: What Mick Jagger and Biotech Start-Ups Have in Common
June 18, 2013Jennifer James, 2013 PEI Investor Relations Forum "Fundraising the next generation"

Media Contact

Jennifer James
VP of Marketing and Investor Relations
Sofinnova Ventures
jennifer@sofinnova.com
(650) 681-8429